Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Briacell Therapeutics Corp (BCTXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 14,254
  • Shares Outstanding, K 164,024
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,250 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/27/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0710 +22.39%
on 02/26/19
0.0984 -11.69%
on 03/20/19
+0.0071 (+8.90%)
since 02/22/19
3-Month
0.0495 +75.56%
on 12/27/18
0.0984 -11.69%
on 03/20/19
+0.0269 (+44.83%)
since 12/21/18
52-Week
0.0495 +75.56%
on 12/27/18
0.1350 -35.63%
on 06/19/18
-0.0114 (-11.60%)
since 03/21/18

Most Recent Stories

More News
BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell Welcomes BioPharma Industry Experts to its Board of Directors

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announces...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell Therapeutics Corp. Highlights Recent Clinical and Scientific Achievements in Exclusive Audio Interview with NetworkNewsWire

via NetworkWire - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell Announces C$500,000 Equity Investment by BriaCell Director

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences

BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell Appoints Jamieson Bondarenko to its Board of Directors

BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase(TM) 2019 and Presentation at Keystone Symposia Conference

-- Completed development of a novel frozen formulation of Bria-IMT(TM) for on-demand shipment to clinical sites to accommodate higher patient volumes at reduced per-dose costs.

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA(R) at a Major Breast Cancer Conference

-- Interim data indicate an excellent safety profile for the combination regimen in advanced breast cancer patients. Initial efficacy data is expected in first quarter of 2019;

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA(R) Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium

-- Positive proof of concept data with Bria-IMT(TM) Monotherapy will highlight potent anti-tumor activity and an excellent safety profile for Bria-IMT(TM) in advanced breast cancer.

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)
MRK : 82.29 (-0.80%)
BriaCell Activates A Clinical Site in Florida for Phase IIa Study of its Lead Candidate in Advanced Breast Cancer

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that Sylvester...

BCTXF : 0.0869 (+7.15%)
BCT.VN : 0.105 (-8.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More Share

Trade BCTXF with:

Key Turning Points

2nd Resistance Point 0.0869
1st Resistance Point 0.0869
Last Price 0.0869
1st Support Level 0.0869
2nd Support Level 0.0869

See More

52-Week High 0.1350
Fibonacci 61.8% 0.1023
Fibonacci 50% 0.0923
Last Price 0.0869
Fibonacci 38.2% 0.0822
52-Week Low 0.0495

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar